Clonidine (Catapres)

Medication Information & Treatment Considerations

Clonidine (Catapres) is a prescription medication that may be considered by a licensed psychiatric provider as part of a treatment plan when clinically appropriate. Treatment recommendations are based on an individual’s symptoms, medical history, treatment goals, and overall clinical evaluation. Clonidine works by affecting alpha-2 adrenergic receptors involved in regulating attention, impulse control, arousal, and the body’s stress response. Individual experiences with medication vary, and treatment outcomes depend on many factors unique to each person. Clonidine is not a controlled substance and must be prescribed by a licensed psychiatric provider. Through Telemynd, medication may be prescribed following a secure virtual evaluation when clinically appropriate. Many insurance plans cover clonidine, and generic options are widely available. Some people may experience side effects such as drowsiness, dizziness, fatigue, dry mouth, or low blood pressure, particularly when starting treatment or adjusting dosage. Your provider will monitor your response to treatment and make adjustments as needed.

Important Safety Information

Clonidine may lower blood pressure and heart rate and can cause dizziness, drowsiness, or lightheadedness in some individuals. This medication may affect alertness and may not be appropriate for everyone. Clonidine should not be stopped abruptly without medical supervision, as sudden discontinuation may lead to increases in blood pressure or other symptoms. Before starting or changing any medication, discuss potential risks, benefits, side effects, warnings, and drug interactions with your healthcare provider. For complete prescribing information, medication warnings, precautions, contraindications, drug interactions, and the FDA-approved Medication Guide, please review the current FDA-approved prescribing information for Clonidine (Catapres).

Educational Notice

This content is provided for informational and educational purposes only and should not be considered medical advice, treatment recommendations, or a guarantee that any medication will be prescribed. Medication decisions are made by licensed healthcare providers following a comprehensive clinical evaluation and consideration of individual needs.

Last reviewed: June 2026. Prescribing information may change. Refer to the current FDA-approved labeling for the most up-to-date safety information.

Previous
Previous

Minipress (Prazosin)

Next
Next

Strattera (Atomoxetine)